Jenrry Mejia's PED use, which has now led to an MLB lifetime ban, may have cost him roughly $47 million in future contract earnings, according to Tom Verducci of Sports Ilustrated.
The Mets still have control over Mejia and have the ability to tender him a contract after this season, Ken Davidoff of the New York Post notes (Feb. 15).
However, Mejia has already missed the chance to appeal his suspension, meaning the earliest he'd be eligible to return to the majors is 2018.
MLB suspended Mejia, 26, for life after he tested postive for PED use for a third time over an 11-month span. He is the first player to receive a permanent suspension related to performance-enhancing substances.
Verducci takes into account his age, arbitration figures and future contracts Mejia may have signed based off what comparable relievers have received in recent seasons, if he was able to stay clean.
Mejia can apply for reinstatement in one-year but his suspension must last at least two years. The commissioner has to decide on Mejia's reinstatement within 30 days of his request, according to Joel Sherman.